Key steps in pursuing a strategy of active surveillance for very low-risk prostate cancer

In this interview, Christopher P. Evans, MD, discusses the use of active surveillance in men with low-risk prostate cancer. Evans is professor and chair of the Department of Urologic Surgery at the University of California, Davis, School of Medicine. He was interviewed by Urology Times® Editorial Consultant J. Brantley Thrasher, MD, executive director of the American Board of Urology, Charlottesville, Virginia.

More videos:

App facilitates assessment of urologic chronic pelvic pain syndrome​

Testosterone therapy does not appear to worsen outcomes in men with COVID-19​

HIFU for prostate cancer: How it works, criteria for treatment, and contraindications​